Nature Communications has published a Retraction Note for the study “Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma.” The paper examined how proteomic data could distinguish clinically relevant groups within this cancer type.
The retraction concerns research associated with the State Key Laboratory of Genetic Engineering, the Collaborative Innovation Center for Genetics and Development, the School of Life Sciences, the Institutes of Biomedical Sciences and the Human Phenome Institute. These affiliations were listed in the publication information.
The available notice identifies the article as retracted but does not provide further details about the reason in the supplied summary. The record remains relevant to researchers tracking proteomics, cancer classification and soft tissue sarcoma studies.